1. Home
  2. IMUX vs PRPL Comparison

IMUX vs PRPL Comparison

Compare IMUX & PRPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMUX
  • PRPL
  • Stock Information
  • Founded
  • IMUX 2016
  • PRPL 2010
  • Country
  • IMUX United States
  • PRPL United States
  • Employees
  • IMUX N/A
  • PRPL N/A
  • Industry
  • IMUX Biotechnology: Pharmaceutical Preparations
  • PRPL Home Furnishings
  • Sector
  • IMUX Health Care
  • PRPL Consumer Discretionary
  • Exchange
  • IMUX Nasdaq
  • PRPL Nasdaq
  • Market Cap
  • IMUX 86.3M
  • PRPL 90.3M
  • IPO Year
  • IMUX N/A
  • PRPL N/A
  • Fundamental
  • Price
  • IMUX $0.95
  • PRPL $1.10
  • Analyst Decision
  • IMUX Strong Buy
  • PRPL Buy
  • Analyst Count
  • IMUX 6
  • PRPL 3
  • Target Price
  • IMUX $12.67
  • PRPL $1.70
  • AVG Volume (30 Days)
  • IMUX 1.0M
  • PRPL 533.6K
  • Earning Date
  • IMUX 02-20-2025
  • PRPL 03-11-2025
  • Dividend Yield
  • IMUX N/A
  • PRPL N/A
  • EPS Growth
  • IMUX N/A
  • PRPL N/A
  • EPS
  • IMUX N/A
  • PRPL N/A
  • Revenue
  • IMUX N/A
  • PRPL $504,838,000.00
  • Revenue This Year
  • IMUX N/A
  • PRPL N/A
  • Revenue Next Year
  • IMUX N/A
  • PRPL $1.89
  • P/E Ratio
  • IMUX N/A
  • PRPL N/A
  • Revenue Growth
  • IMUX N/A
  • PRPL N/A
  • 52 Week Low
  • IMUX $0.92
  • PRPL $0.75
  • 52 Week High
  • IMUX $2.11
  • PRPL $2.33
  • Technical
  • Relative Strength Index (RSI)
  • IMUX 44.34
  • PRPL 53.43
  • Support Level
  • IMUX $0.94
  • PRPL $1.04
  • Resistance Level
  • IMUX $1.02
  • PRPL $1.10
  • Average True Range (ATR)
  • IMUX 0.06
  • PRPL 0.10
  • MACD
  • IMUX 0.00
  • PRPL -0.01
  • Stochastic Oscillator
  • IMUX 44.96
  • PRPL 31.75

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

About PRPL Purple Innovation Inc.

Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms, and other products. It sells its products through online channels, traditional wholesale partners and third-party online retailers.

Share on Social Networks: